Press Releases

Alkeus Pharmaceuticals to Present at the 4th Annual Evercore ISI HealthCONx Conference

FDA Grants Alkeus Pharmaceuticals Breakthrough Therapy Designation for ALK-001 (C20-D3-vitamin A) for the Treatment of Stargardt Disease